Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Thymosin-beta-4-fragment

Ac-SDKP, Goralatide, Seraspenide

Quick Stats
Studies 83
Trials 3
Score 1
1982 pubmed

Chemical characterization of thymosin beta 4.

Low. T L TL; Goldstein. A L AL

Key Findings

  • Thymosin beta‑4 is a 43‑amino‑acid peptide (MW ≈ 4982 Da, pI ≈ 5.1) with an acetylated N‑terminus
  • It triggers terminal deoxynucleotidyl transferase expression in murine thymocytes
  • It inhibits migration of macrophages and contains two predicted helical regions

Practical Outcomes

  • The paper only provides basic biochemical info and early animal‑cell effects, so there’s no actionable dosage or protocol for humans. Biohackers would need much more safety and efficacy data before considering any self‑experiments with thymosin beta‑4.

Summary

Scientists figured out the exact makeup of a tiny protein called thymosin beta‑4, including its size, charge, and that it has an acetyl group at the start. They showed it can boost a specific enzyme in mouse immune cells and can slow down macrophage movement, but they didn’t test it in people or give any usage guidelines.

Abstract

As part of our ongoing investigations on the endocrine thymus, we have isolated and purified to homogeneity a hormone-like peptide which we have termed thymosin beta 4. Thymosin beta 4 has Mr = 4982 and an isoelectric point of 5.1. The complete amino acid sequence of this polypeptide has been established by automated Edman degradation as well as by manual sequence analysis. Thymosin beta 4 is composed of 43 amino acid residues with acetylserine at the NH2 terminus. This molecule induces expression of terminal deoxynucleotidyl transferase in transferase-negative murine thymocytes in vivo and in vitro. It also exhibits ability to inhibit the migration of macrophages. Comparison of the sequence of thymosin beta 4 to other thymic hormones or other published protein sequences does not reveal any statistically significant relationship. Two helical regions were identified in the structure using data for prediction of protein conformation. It is proposed that thymosin beta 4 is one of the biologically active peptides present in thymosin fractions 5 and 5A which participate in the regulation, differentiation, and function of thymus-derived lymphocytes and may also act directly or indirectly on macrophages and perhaps other cells involved in cell-mediated immunity.

Study Information

Provider

pubmed

Year

1982

Date

1982-01-25T00:00:00.000Z